Herpes simplex Virus 1 gG antibody | LP10 (B018)
Clone LP10 is specific for HSV-1 envelope glycoprotein G and has no neutralizing activity in the absence or presence of complement.
- Target Species
- Product Form
- Purified IgG - liquid
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
0.09% Sodium Azide
- HSV-1 strains HFEM and SC16.
- Approx. Protein Concentrations
- IgG concentration 1.0 mg/ml
- Fusion Partners
- Spleen cells from immunised Balb/c mice were fused with cells of the NS1 myeloma cell line.
- This product is shipped at ambient temperature. It is recommended to aliquot and store at -20°C on receipt. When thawed, aliquot the sample as needed. Keep aliquots at 2-8°C for short term use (up to 4 weeks) and store the remaining aliquots at -20°C.
Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.
- 12 months from date of despatch
- For research purposes only
Applications of Herpes simplex Virus 1 gG antibody
|Application Name||Verified||Min Dilution||Max Dilution|
|Immunohistology - Frozen||1/100|
Secondary Antibodies Available
Product Specific References
References for Herpes simplex Virus 1 gG antibody
Richman, D.D. et al. (1986) Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it.
J Virol. 57 (2): 647-55.
Peek, R. et al. (2002) Herpes simplex virus infection of the human eye induces a compartmentalized virus-specific B cell response.
J Infect Dis. 186: 1539-46.
Fluorescent SpectraviewerWatch the Tool Tutorial Video ▸
How to Use the SpectraviewerWatch the Tool Tutorial Video ▸
- Start by selecting the application you are interested in, with the option to select an instrument from the drop down menu or create a customized instrument
- Select the fluorophores or fluorescent proteins you want to include in your panel to check compatibility
- Select the lasers and filters you wish to include
- Select combined or multi-laser view to visualize the spectra